Overview
Arthur Hooberman is an Oncologist practicing medicine in Park Ridge, Illinois.
Dr. Hooberman is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Gastrostomy.
He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 2 clinical trials.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
Locations
1700 Luther Ln, Park Ridge, IL 60068
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
UChicago Medicine River East
Sonali Smith is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Smith is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Smith is board certified in Medical Oncology and Practicing Since2001.
Leo Gordon is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 53 years. Dr. Gordon is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Gordon is board certified in American Board Of Internal Medicine - Hematology (Certified).
Rush University Medical Center
Philip Bonomi is an Oncologist practicing medicine in Chicago, Illinois. Dr. Bonomi is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
Frequently Asked Questions about Dr. Arthur Hooberman
How do I make an appointment with Dr. Arthur Hooberman?
You can book an appointment with Dr. Arthur Hooberman by calling their office at 847-268-8200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Arthur Hooberman a top-rated expert for Pleuropulmonary Blastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Arthur Hooberman is classified as an Advanced expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Arthur Hooberman specialize in?
While Dr. Arthur Hooberman is a Oncology, they have specific expertise in Pleuropulmonary Blastoma, Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Arthur Hooberman participate in research or clinical trials?
Yes. Dr. Arthur Hooberman has published 2 articles and abstracts on conditions like Pleuropulmonary Blastoma. You can view a list of Dr. Arthur Hooberman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Arthur Hooberman accept my insurance?
Dr. Arthur Hooberman accepts most major insurance plans, including Cigna. We recommend calling the office directly at 847-268-8200 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Hooberman isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Laryngeal CancerDr. Hooberman isAdvanced. Learn about Laryngeal Cancer.
- Lung AdenocarcinomaDr. Hooberman isAdvanced. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Hooberman isAdvanced. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Hooberman isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Hooberman isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Experienced
- AngiosarcomaDr. Hooberman isExperienced. Learn about Angiosarcoma.
- AstrocytomaDr. Hooberman isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Hooberman isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Brain TumorDr. Hooberman isExperienced. Learn about Brain Tumor.
- Breast CancerDr. Hooberman isExperienced. Learn about Breast Cancer.
- Chronic Graft Versus Host Disease (cGvHD)Dr. Hooberman isExperienced. Learn about Chronic Graft Versus Host Disease (cGvHD).